You just read:

Eiger Updates Progress in Clinical Development Program for Exendin 9-39 to Treat Post-Bariatric Hypoglycemia (PBH)

News provided by

Eiger BioPharmaceuticals, Inc.

Nov 29, 2016, 08:00 ET